Enhancements support ADA and NAb testing workflows, boosting lab efficiency and regulatory compliance for drug development.

Thermo Fisher Scientific Inc., will showcase its latest innovations enabling the molecule-to-medicine journey and host a series of sessions that feature industry developments during CPHI Milan 2024, Oct. 8-10, in Milan, Italy.

BD (Becton, Dickinson and Company) (NYSE: BDX), and ten23 health, announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

BD (Becton, Dickinson and Company), will highlight its newest innovations in drug delivery systems at CPhI Milan 2024 on October 8th and 9th in Milan, Italy.

Beckman Coulter Life Sciences, announces the appointment of Joe Fox as President of the company effective immediately.

Since 1995, the Eppendorf Award for Young European Investigators, endowed with 20,000 EUR, has honored outstanding achievements in the field of biomedical research in Europe once a year.

To provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutical companies, Thermo Fisher Scientific Inc. is expanding its oral solid dose (OSD) footprint with a $22-million total investment.

BOC Sciences is pleased to announce its new Scholarship Program aimed at supporting college students pursuing degrees in chemistry-related fields.

Quell Therapeutics Ltd (“Quell” or “the Company”), and eXmoor pharma (“eXmoor”), announce a strategic partnership for the manufacture of multiple autologous engineered CAR-Treg cell therapies in Quell’s pipeline targeting autoimmune diseases.

PlaqueTec, and RxCelerate, announced the successful completion of a collaboration to assess small molecules identified from an initial cheminformatics drug screen in a bespoke cell-based assay.